Compare SOUN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOUN | ATRC |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2021 | 2005 |
| Metric | SOUN | ATRC |
|---|---|---|
| Price | $6.57 | $53.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $15.00 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 23.4M | 665.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 73.08 | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | $40.76 | $15.27 |
| Revenue Next Year | $20.02 | $12.21 |
| P/E Ratio | ★ N/A | $286.22 |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $5.65 | $25.36 |
| 52 Week High | $22.17 | $53.50 |
| Indicator | SOUN | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 78.78 |
| Support Level | $6.38 | $26.95 |
| Resistance Level | $6.73 | N/A |
| Average True Range (ATR) | 0.31 | 2.00 |
| MACD | -0.08 | 0.15 |
| Stochastic Oscillator | 13.65 | 83.69 |
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers. The company's voice AI delivers speed and accuracy in numerous languages to product creators and service providers across retail, financial services, healthcare, automotive, smart devices, and restaurants via groundbreaking AI-driven products like Smart Answering, Smart Ordering, Dynamic Drive-Thru, and Amelia AI Agents.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.